Get started

Biotech

ACST is now in the spotlightSo today I sold my NCLH and Bitcoin and went into ACST or Acasti Pharma. We made nice gains with NCLH with a killer premarket but leveled off back under closed, but than exploded 6% and going even higher after I sold at 11.22 with my buy at 9.88. Bitcoin has been bouncing between 1-2%, which had nice support at the emas this morning. is why ACST also caught my eye. How did i hear about ACST well someone brought up that Amarin or AMRN open 60% down with ending in a 70% lose today and ACST is its competitor, with it being in penny stock territory. ACST also has gone to the FDA planning on getting in meetings to move on with their drug, I think Its CaPre which is "CaPre is intended to be used as a therapy in conjunction with positive lifestyle changes including diet, and is to be administered either alone or with other drug treatment regimens such as statins (a class of drug used to reduce cholesterol levels). " Which this market is a 50billion dollars with this stock being about 35million dollars valuation with the company owning about 90million and public owning about 70million shares. With their drug ending its testing phase its now up to ACST to work with the FDA, which could happen anytime between now or in 70days is how long till a respose will take for the FDA. There is a high chance it will get approve from many spectators. Now technicals -AMRN got hit hard, yet ACST hasn't moved much but its penny stock. -From its low to now its up about 49%, yet from were its been trading at the $2.30ish is down 82%, so hugh upside with a 450% gain back to original trading range with it going higher as of $3 before the sell preasure hit. ($3 was the original target from what I read with a target in the $8 range if the FDA approves of the drug) -MACD on the hourly is bearish -Volume is very low which we could expect a big move soon -RSI is heading towards overbought, yet its netural to me -So far on active hours and premarket its holding the 50ema on the hourly, yet we would need a break above the others. maintaining above the the 50ema is always a bullish sign, yet it will need to hold and see upward price movement. I'm a long buyer just cause the price is near its lowest even though it could go lower, yet I don't see much more room to drop with the marketcap. We would have to wait till premarket tonight for this stock and hopefully its bullish.
ALong
by nathanielx9
$AYTU can rise in the next daysContextual immersion trading strategy idea. Aytu BioScience has a strong upward trend. The company develops and commercializes novel products in the field of hypogonadism (low testosterone), cough and upper respiratory symptoms, insomnia, and male infertility. Due to the spread of the COVID-19, the demand for the company's services rose. Today Aytu BioScience received confirmation from the FDA that it may begin distribution of its COVID-19 IgG/IgM Rapid Test throughout the U.S. — finance.yahoo.com This and other conditions can cause a rise in the share price in the next days. So I opened a long position from $1,85; stop-loss — $1,65. Information about take-profits will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
NASDAQ:AYTULong
by KozakHlib
2
$GILD can rise in the next daysContextual immersion trading strategy idea. Gilead Sciences has a strong upward trend. The company is developing a treatment for COVID-19 now. Due to the spread of the virus, this company looks very attractive and has a potential for success. This and other conditions can cause a rise in the share price in the next days. So I opened a long position from $80,74; Information about stop-loss and take-profits will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
NASDAQ:GILDLong
by KozakHlib
GILEAD In the LeadCharting historical Support and Resistance levels. Gilead was on track to have an improved 2020 financials wise even before Corona Market. They are the front runner for vaccine in terms of drugs already in trials to treat similar COVID diseases. They also have two drugs being tested and waiting to be approved in China for cancer drugs which will continue to bolster stock if looking to hold long term. Many smaller biotech stocks with few to no results were losing value even in the bull market of last few months, now once Corona fears subside or companies have patented successful drugs, those companies will go back to losing their value and I think player like GILD are here to eat that up for those still looking to invest in biotech, but not penny stocks. Considering how manic this run up has been, the tests at the historical levels have been met and beaten, just not for as long as we'd like to see. Seems likely to have a small correction 03/09 as it's now at the level it was previously brought down sharply, but if mooning through 82.50 without dropping below 78.50 then it's clear to have another discovery between 85-90. Summary: Good long term investment. Good swing trade. Scalping could cause a shortened lifespan, though huge room for profit (and loss =D)
NASDAQ:GILD
by DiscountedCokeFlow
Novavax (NVAX) - Vaccine Testing - SARS, MERS, SARS-CoV-2 (2019)This is an interesting idea based on outbreaks of SARS, MERS, and SARS-CoV-2 (2019). Novavax successfully created vaccines for SARS, MERS, and are on track to create one for SARS-CoV-2 (2019) - ir.novavax.com Vaccine in development for SARS-CoV-2 (2019): seekingalpha.com Is this a good investment? If the vaccination is successful and/or coronavirus outbreak continues, it could trend upwards significantly. Disclaimer: This is not financial advice. Just my own opinion based on research. Important Notes: For your own safety, the CDC recommends you WASH YOUR HANDS FREQUENTLY. COVER YOUR MOUTHS WHEN YOU COUGH/SNEEZE.
NASDAQ:NVAXLong
by traderman001
2
BEAT- BEAST is about to be unleashed...Positional/swing tradeBEAT is your prototypical aggressive growth stock- Strong future growth potential with good earning and revenue track record ... If you can overlook its debt level. This beast was tamed for a while after its share price skyrocketed from $25 to almost $80 , but it is ready to unleash its fury again. But first, I think the pullback is in the store facing key resistance lvl in confluence with ichi and BB on the weekly timeframe. In addition, short % of float is around 10%. However, it is a bullish sign when price hovers below the key resistance lvl rather than experiencing outright price rejection. My buy zone is between $45 to $55 for the positional trade. The long term trendline and S/R flip below this price range will act as a strong support. Click the like button and follow me if you like my analysis :D
NASDAQ:BEAT
by Libratus
Is CRSP trading in a descending triangle or bull flag?Key Takeaways A descending triangle is a signal for traders to take a short position to accelerate a breakdown. A descending triangle is detectable by drawing trend lines for the highs and lows on a chart. A descending triangle is the counterpart of an ascending triangle, which is another trend line based chart pattern used by technical analysts. Bullish flag formations are found in stocks with strong uptrends. They are called bull flags because the pattern resembles a flag on a pole. The pole is the result of a vertical rise in a stock and the flag results from a period of consolidation. The flag can be a horizontal rectangle, but is also often angled down away from the prevailing trend. Another variant is called a bullish pennant, in which the consolidation takes the form of a symmetrical triangle. The shape of the flag is not as important as the underlying psychology behind the pattern. Basically, despite a strong vertical rally, the stock refuses to drop appreciably, as bulls snap up any shares they can get. The breakout from a flag often results in a powerful move higher, measuring the length of the prior flag pole. It is important to note that these patterns work the same in reverse and are known as bear flags and pennants. EOM.
NASDAQ:CRSPLong
by ScotianBot
So Tight I can Barley Breath!!!!I decided to look at something new: Vwap: Week, Month, and Year. I have highlights of two patterns following different setups but similar Indicator patterns. **Also Yes I am aware the VWAP Year is not that impressive from only being a month and a half into the year!! Notes: -Notice the Flat top Breakout (FTB) in the first shaded area 3 taps per normal healthy FTB -Currently a nice Flag Breakout could be setting up nicely. -The Vwaps and Moving averages of setting up nicely consolidating to a tight range, hinting an explosive move ahead. -Crossover of Year Vwap catapulted us through the Flat top -We are about to cross through the Year Vwap again. -OBV: Still holding nice trend upward -Ladies and Fellars start your engines!! BUY BUY BUY!!! If you have an Opinion on this let me know!
ALong
by JaxelCap
1
9EMA Support of the Gods and Bounce to the HeavensI will keep this one simple. We are closing in on a major bullish breakout. As we approach the top of the larger daily flag, you can see the smaller time frame Flat top setup. Here is the beautiful part of this pattern in pattern play. we are sitting on Super strong support of the 9EMA, Its tight Its right! That 9 EMA will help push through the Flat top for a Flat top Breakout! AND THEN!!!!! Boom that Breakout power will push us through the Flag into the unknown ( $2?? $5??? $10??? $1M?????(lol)) All we need is a Catalyst!! OH DAMN we got um incoming!!! SEE you all on the moon!! Buy BUY BUY!!
ALong
by JaxelCap
Exicure Inc. P-Modeling Pt Z. The Cajun Ship of ObliterationWelcome Hyperspace Archaeologists, Come for the laughs, stay for the Art. ___________________ Find the "we are here" bubble. I am most likely wrong... Meh . Who cares. but what... if.. good enough for me! All in. #pewpeww __________________________________ Trade Taken: Entry Range is $2.38 - $2.45 Target $8.60 Hold until April 2021 Technical. One Cajun Ship nestled w/ Root-1-2-3-4-5 & Root-W-X-Y-X-Z TimeFrame: 1-Day. _____________________________ Failure is a necessary presupposition to success. Laugh with me into madness. Thanks for Pondering the Unknown with Me, Glitch420 *Disclaimer: If you seizure prone, turn the brightness all the way up for extra eye bleed. This is financial advice.
NASDAQ:XCURLong
by Glitch420
1
Next biotech stock to shoot up? Firdapse Spinal Muscular Atrophy (SMA) Type 3 **** Phase 2 data due 1H 2020 Firdapse MuSK-antibody positive myasthenia gravis (MuSK-MG) **** Phase 3 data due 1H 2020 Short Float = 13.23% Broke out of triangle, looking for a small pullback to the cloud / support line, have a stop under suport line at 4.20 and Target at 7.50 for at possible 70% upside Gain. Cloud turned bullish and 9 EMA crossed 21 in an upside fashion. **'*** This is not a recommendation for entering a position, please do your own Due dillligence ******
NASDAQ:CPRXLong
by Charlestrad3r
3
Photocure $PHO.OL trade above last major resistance on US patentPatent covering the use of Blue Light Cystoscopy (BLC®) with Hexvix as neoadjuvant* therapy in the treatment of bladder cancer in patients who are scheduled for a cystectomy. Early stage study results have shown an antitumor effect and induced systemic immune effects of hexaminolevulinate (HAL) and blue light in an orthotopic model of rat bladder cancer. Photocure has the intention to further investigate Hexvix for its therapeutic effect and the patent is a result of Photocure’s continued focus on securing intellectual property rights for its research results and pipeline activities. The patent was issued on 11 February 2020 and will expire in December 2036. * Neoadjuvant therapy: treatment (such as chemotherapy) administered before primary cancer treatment (such as surgery) to enhance the outcome of primary treatment Photocure OSL:PHO IR news release: photocure.com
OSL:PHOLong
by savepiginvest
Ladies and Fellas Start your Engines!!!We are ready!!! The presentation today will create the catalyst needed for Greatness and Glory!!! We have put up with that Bear crap for the last time, now lets make us some millionaires and cure some F**kin Cancer!! Notes: OBV: About to Break through top of its Trend! -Chart shows a slightly modified(Accelerated) Price projection. -Coming out a strong accumulation phase. -Continuation of Longer term Cup and Handle. Buy Buy Buy Let me know your Thoughts!!!
ALong
by JaxelCap
Curls for the Girls!! Breakout imminent!!Its been a while since I have published anything but this stock is ready for greatness and glory!! With upcoming news on the horizon ( presentation coming up) and a lot of speculation on potential Merck acquisition. The TA combined is ready to rocket!!! Notes: -200, 50, 20, and 9 EMA all curling right under the price(Curls for the girls).. This indicates a Strong level of support and momentum coming into play. -The Curls for the Girls is the powerhouse setup needed for breaking through this Bullish pennant. I hope you all buy now before I buy it all up!!! Good Luck. Let me know your Thoughts!
ALong
by JaxelCap